IL162768A0 - Method of treatment of a patient requiring analgesia - Google Patents

Method of treatment of a patient requiring analgesia

Info

Publication number
IL162768A0
IL162768A0 IL16276803A IL16276803A IL162768A0 IL 162768 A0 IL162768 A0 IL 162768A0 IL 16276803 A IL16276803 A IL 16276803A IL 16276803 A IL16276803 A IL 16276803A IL 162768 A0 IL162768 A0 IL 162768A0
Authority
IL
Israel
Prior art keywords
treatment
patient requiring
analgesia
devazepide
requiring analgesia
Prior art date
Application number
IL16276803A
Other languages
English (en)
Original Assignee
Ml Lab Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ml Lab Plc filed Critical Ml Lab Plc
Publication of IL162768A0 publication Critical patent/IL162768A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4468Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Laser Surgery Devices (AREA)
  • Radiation-Therapy Devices (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Electrotherapy Devices (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Confectionery (AREA)
IL16276803A 2002-01-22 2003-01-22 Method of treatment of a patient requiring analgesia IL162768A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0201367.0A GB0201367D0 (en) 2002-01-22 2002-01-22 Composition
PCT/GB2003/000221 WO2003061632A1 (en) 2002-01-22 2003-01-22 Method of treatment of a patient requiring analgesia

Publications (1)

Publication Number Publication Date
IL162768A0 true IL162768A0 (en) 2005-11-20

Family

ID=9929492

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16276803A IL162768A0 (en) 2002-01-22 2003-01-22 Method of treatment of a patient requiring analgesia

Country Status (13)

Country Link
EP (1) EP1467718B1 (de)
JP (1) JP2005521655A (de)
AT (1) ATE310509T1 (de)
BR (1) BR0307022A (de)
CA (1) CA2473884A1 (de)
DE (1) DE60302431T2 (de)
ES (1) ES2253662T3 (de)
GB (1) GB0201367D0 (de)
IL (1) IL162768A0 (de)
MX (1) MXPA04007030A (de)
NO (1) NO20042758L (de)
PL (1) PL371523A1 (de)
WO (1) WO2003061632A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0213198D0 (en) * 2002-06-10 2002-07-17 Ml Lab Plc Method of treatment
GB0406280D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Chemical compounds
CA2622592A1 (en) 2005-09-19 2007-03-29 Arrow Therapeutics Limited Benzodiazepine derivatives for treating hepatitis c infection
US8093261B2 (en) 2006-10-24 2012-01-10 The Johns Hopkins University Rapid release mini-tablets provide analgesia in laboratory animals
EP2197448A4 (de) * 2007-09-12 2010-11-17 Elan Pharma Int Ltd Dosierplan
JP5938409B2 (ja) * 2010-09-03 2016-06-22 ゾエティス・ベルジャム・エス・アー 高用量ブプレノルフィン組成物及び使用方法
US20120171277A1 (en) * 2011-01-03 2012-07-05 Royds Robert B Abuse resistant transdermal drug delivery patch including a release-enhanced antagonist
US10729687B1 (en) 2019-07-09 2020-08-04 Orexo Ab Pharmaceutical composition for nasal delivery
US10653690B1 (en) 2019-07-09 2020-05-19 Orexo Ab Pharmaceutical composition for nasal delivery
HRP20221361T1 (hr) 2020-05-18 2023-01-06 Orexo Ab Novi farmaceutski sastav za davanje lijeka
KR20240103005A (ko) 2021-11-25 2024-07-03 오렉쏘 에이비 아드레날린을 포함하는 약학적 조성물
US12090151B1 (en) 2023-05-12 2024-09-17 Michael Guarnieri Injectable sustained release buprenorphine formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1564039A (en) * 1976-12-09 1980-04-02 Berger F Analgesic compositions comprising dextropropoxyphene and benzodiazepines
US5153191A (en) * 1991-08-20 1992-10-06 Warner-Lambert Company Cholecystokinin antagonists useful for treating depression
GB9721746D0 (en) * 1997-10-15 1997-12-10 Panos Therapeutics Limited Compositions

Also Published As

Publication number Publication date
CA2473884A1 (en) 2003-07-31
EP1467718B1 (de) 2005-11-23
MXPA04007030A (es) 2004-10-11
DE60302431D1 (de) 2005-12-29
PL371523A1 (en) 2005-06-27
GB0201367D0 (en) 2002-03-13
JP2005521655A (ja) 2005-07-21
DE60302431T2 (de) 2006-07-27
WO2003061632A1 (en) 2003-07-31
BR0307022A (pt) 2004-11-03
ATE310509T1 (de) 2005-12-15
NO20042758L (no) 2004-09-22
ES2253662T3 (es) 2006-06-01
EP1467718A1 (de) 2004-10-20

Similar Documents

Publication Publication Date Title
WO2005058233A3 (en) Methods for treatment of acute pancreatitis
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
WO2000021515A3 (en) Intranasal codeine for the rapid suppression of cough and rapid relief of pain
WO2003080022A3 (en) Analgesics for nasal administration
NZ508526A (en) Opioid formulations for treating pain
AUPN603895A0 (en) Production of analgesic synergy by co-administration of sub-analgesic doses of two strong opioids
AU3898700A (en) Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages
WO2004000354A3 (en) Method of treating the syndrome of lipodystrophy
UA88270C2 (ru) Фармацевтический препарат и его применение для профилактики удара, диабета
PL350583A1 (en) Combinations of formoterol and a tiotropium salt
PL312219A1 (en) Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids
AP2004003157A0 (en) Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
ES2197792A1 (es) Formulaciones farmaceuticas y metodos que contienen morfina intranasal.
GB0201367D0 (en) Composition
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
RO116771B1 (ro) Metodă pentru prevenirea sau tratamentul dependenţei, toleranţei sau abuzului de benzodiazepine
WO2001045715A3 (en) Combinations of an adenosine a1 agonist with an opioid and their use in the treatment of pain
IL166596A0 (en) Salt of morphine-6-glucoronide
WO2002065989A3 (en) Aminoglycoside treatment for lysosomal storage diseases
GB0020504D0 (en) Therapeutic method
SE9902597D0 (sv) New use
TW200503683A (en) Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
EP0799618A3 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
HUP0402326A2 (hu) Gyógyszerkészítmény addikció megelőzésére fájdalom kezelésében
EP0906757A3 (de) Analgetische Zusammensetzung welche Moxonidine und ein Opioid-Analgetika enthält